PepsiCo has released its second-quarter financial results, revealing a contrast between robust international growth and diminishing demand within the North American market.

百事公司公布了第二季度的財務結果，顯示國際市場的強勁增長與北美市場需求下降形成對比。

The organization's fiscal performance was characterized by a revenue increase of 6.4% to $24.18 billion, surpassing analyst projections. However, equity valuation declined by approximately 5% following the announcement. This market reaction is attributed to the maintenance of existing full-year guidance—projecting organic revenue growth of 2% to 4% and core constant-currency earnings per share growth of 4% to 6%—rather than an upward revision, despite the revenue beat.

該組織的財務表現特徵為營收增加6.4%至241.8億美元，超越分析師預期。然而，公告後股價下跌約5%。市場反應歸因於公司維持現有的全年指引——預計有機營收增長2%至4%，且核心恆定匯率每股盈餘增長4%至6%——而非上調，儘管營收表現優於預期。

Domestic operational challenges are primarily linked to macroeconomic headwinds. The North American beverage sector experienced a 4% volume contraction, while food volumes remained stagnant. Management attributes this attrition to the erosion of consumer purchasing power, exacerbated by inflationary pressures and elevated fuel costs resulting from geopolitical instability involving Iran. Consequently, consumers have demonstrated a propensity for smaller packaging and lower-cost alternatives. In response, the company implemented price reductions of up to 15% on primary snack brands to incentivize consumer retention.

國內營運挑戰主要與宏觀經濟逆風相關。北美飲料部門銷量萎縮4%，而食品銷量則持平。管理層將此衰退歸因於消費者購買力下降，且受通膨壓力及伊朗地緣政治不穩定導致的燃料成本上升而加劇。因此，消費者表現出對小包裝及低成本替代品的偏好。作為回應，公司對主要零食品牌實施最高15%的降價，以激勵消費者留存。

Conversely, international markets, including China, India, the U.K., Poland, and Germany, provided a critical offset, driving a 2.4% increase in organic revenue. To mitigate long-term demand volatility and adapt to evolving health consciousness—partially influenced by the emergence of GLP-1 medications—PepsiCo is diversifying its portfolio. This strategic pivot includes the introduction of low-sugar and protein-enriched products. CFO Steve Schmitt indicated that while input costs are expected to rise in the latter half of fiscal 2026, these will be partially neutralized through productivity gains and tariff refund claims.

相反地，包括中國、印度、英國、波蘭和德國在內的國際市場提供了關鍵的抵銷，推動有機營收增長2.4%。為了緩解長期需求波動並適應演變中的健康意識（部分受GLP-1藥物出現影響），百事公司正在將其產品組合多元化。這一策略轉型包括推出低糖和高蛋白質產品。財務長Steve Schmitt指出，雖然2026財年下半年的投入成本預計將上升，但將透過生產力提升和關稅退稅申請部分抵銷。

PepsiCo remains in a state of strategic transition, balancing international expansion against a cautious recovery trajectory in North America.

百事公司仍處於策略轉型狀態，在國際擴張與北美謹慎的復甦軌跡之間取得平衡。